Teradyne, INC Form 4 insider transactions

Mercedes Johnson, a Director of Teradyne, Inc, sold 166 shares of common stock on August 3, 2026 for $358.15 per share.

Gregory Stephen Smith, President and CEO and a Director of Teradyne, Inc, sold 4,000 shares of common stock on July 15, 2026 for $356.31 per share.

Marilyn Matz, a Director of Teradyne, Inc, sold 1,200 shares of common stock on July 15, 2026 for $356.31 per share.

Mercedes Johnson, a Director at Teradyne, Inc., reported a sale of common stock under a Rule 10b5-1 trading plan.

Teradyne Director Paul J. Tufano acquired deferred stock units valued at $0 on June 25, 2026, increasing his beneficial ownership.

Teradyne, Inc. reports a Form 4 filing detailing a director's acquisition of deferred stock units.

Teradyne Director Peter Herweck acquired 63 deferred stock units (DSUs) on June 25, 2026, as part of his compensation.

Teradyne Director Marilyn Matz sold 1,200 shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Teradyne President and CEO Gregory Smith sold 4,000 shares of common stock on June 15, 2026, pursuant to a Rule 10b5-1 trading plan.

Director Ernest E. Maddock acquired 2 additional deferred stock units of Teradyne, Inc. through a dividend reinvestment election.

Director Peter Herweck acquired 4 deferred stock units in Teradyne, Inc. through a dividend reinvestment election.

Director Paul J. Tufano acquired 19 deferred stock units in Teradyne, Inc. through a dividend reinvestment election.

Teradyne Inc. executive Jean Pierre Hathout reported the disposal of company shares to cover tax obligations related to vested restricted stock units.

Director Mercedes Johnson of Teradyne, Inc. has reported the sale of 167 shares of common stock under a pre-arranged trading plan.

Teradyne, Inc. reports insider transactions where President of Semiconductor Test, Shannon John Poulin, sold shares and exercised stock options.

Director Marilyn Matz of Teradyne, Inc. reported a transaction involving the sale of 400 shares of common stock on May 21, 2026, executed under a pre-established 10b5-1 trading plan.

Teradyne, Inc. President and CEO Gregory Stephen Smith reported transactions involving company stock, including the acquisition of shares under a 10b5-1 plan and the exercise of stock options.

Teradyne, Inc. Director Marilyn Matz has reported the sale of common stock executed under a pre-arranged 10b5-1 trading plan.

Director Peter Herweck was granted 668 restricted stock units as part of Teradyne's equity compensation plan.

Teradyne Director Mercedes Johnson was granted 668 restricted stock units as part of the company's equity compensation plan.

Teradyne Director Marilyn Matz was granted 668 restricted stock units as part of the company's equity compensation plan.

Director Bridget A. van Kralingen was granted 668 restricted stock units as part of Teradyne's equity compensation plan.

Teradyne Director Paul J. Tufano was granted 668 restricted stock units, vesting by May 2027.

Director Necip Sayiner of Teradyne, Inc. has acquired 668 shares of common stock through restricted stock units.

Director Ernest E. Maddock of Teradyne, Inc. reported the acquisition of 668 restricted stock units.

Teradyne, Inc. director Henry Andrew Chisholm reported the acquisition of 668 shares of common stock.

Teradyne Inc. VP, General Counsel, and Secretary Ryan Driscoll sold 680 shares of common stock for $377.60 per share under a pre-established Rule 10b5-1 sales plan.

Teradyne Inc. reports an executive's sale of 16 shares of common stock on April 8, 2026, as part of a pre-established 10b5-1 trading plan.

Teradyne Director Mercedes Johnson reported a sale of 625 shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Teradyne Inc. reports a transaction where an insider, Shannon John Poulin, sold shares to cover tax obligations related to vested restricted stock units.